Solifenacin treatment for overactive bladder in Hispanic patients : patient-reported symptom bother and quality of life outcomes from the VESIcare® Open-Label Trial
- Author
- CAPO, J. P1 ; LARAMEE, C2 ; LUCENTE, V3 ; FAKHOURY, A4 ; FORERO-SCHWANHAEUSER, S5
[1] Internal Medicine Associates of Atlanta, Atlanta, GA, United States
[2] Clinical Research of West Florida, Inc, Clearwater, FL, United States
[3] Institute for Female Pelvic Medicine, Allentown, PA, United States
[4] Astellas Pharma US Inc, Deerfield, IL, United States
[5] GlaxosmithKline, King of Prussia, PA, United States - Source
International journal of clinical practice (Esher). 2008, Vol 62, Num 1, pp 39-46, 8 p ; ref : 27 ref
- ISSN
- 1368-5031
- Scientific domain
- General medicine general surgery
- Publisher
- Blackwell, Oxford
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Keyword (fr)
- Compte rendu Essai clinique Evolution Hispanique Homme Latinoaméricain Malade Médecine Médicament Pronostic Qualité de vie Solifénacine Symptomatologie Traitement Vessie hyperactive Essai ouvert Essai thérapeutique Antagoniste Anticholinergique Antimuscarinique Pathologie de l'appareil urinaire Pathologie de la vessie Pathologie des voies urinaires Récepteur cholinergique Récepteur muscarinique
- Keyword (en)
- Report Clinical trial Evolution Hispanic Human Latinamerican Patient Medicine Drug Prognosis Quality of life Solifenacin Symptomatology Treatment Overactive bladder Antagonist Anticholinergic agent Antimuscarinic agent Urinary system disease Bladder disease Urinary tract disease Cholinergic receptor Muscarinic receptor
- Keyword (es)
- Informe Ensayo clínico Evolución Hispanos Hombre Latinoamericano Enfermo Medicina Medicamento Pronóstico Calidad vida Solifenacina Sintomatología Tratamiento Vejiga hiperactiva Antagonista Anticolinérgico Antimuscarínico Aparato urinario patología Vejiga patología Vía urinaria patología Receptor colinérgico Receptor muscarínico
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B14 Nephrology. Urinary tract diseases / 002B14E Urinary system involvement in other diseases. Miscellaneous / 002B14E02 Urinary tract. Prostate gland
- Discipline
- Generalities in medical sciences Nephrology. Urinary tract diseases
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 19994186
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1111/j.1742-1241.2007.01644.x 
https://dx.doi.org/10.1111/j.1742-1241.2007.01644.x
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1742-1241.2007.01644.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:165:\"Solifenacin treatment for overactive bladder in Hispanic patients : patient-reported symptom bother and quality of life outcomes from the VESIcare\u00ae Open-Label Trial\";s:9:\"\u0000*\u0000jtitle\";s:50:\"International journal of clinical practice (Esher)\";s:9:\"\u0000*\u0000stitle\";s:28:\"Int. j. clin. pract. (Esher)\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"62\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"39\";s:8:\"\u0000*\u0000epage\";s:2:\"46\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1368-5031\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"CAPO\";s:10:\"\u0000*\u0000aufirst\";s:4:\"J. P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:10:\"LARAMEE, C\";i:1;s:10:\"LUCENTE, V\";i:2;s:11:\"FAKHOURY, A\";i:3;s:23:\"FORERO-SCHWANHAEUSER, S\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:165:\"Solifenacin treatment for overactive bladder in Hispanic patients : patient-reported symptom bother and quality of life outcomes from the VESIcare\u00ae Open-Label Trial\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1742-1241.2007.01644.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:165:\"Solifenacin treatment for overactive bladder in Hispanic patients : patient-reported symptom bother and quality of life outcomes from the VESIcare\u00ae Open-Label Trial\";s:9:\"\u0000*\u0000jtitle\";s:50:\"International journal of clinical practice (Esher)\";s:9:\"\u0000*\u0000stitle\";s:28:\"Int. j. clin. pract. (Esher)\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"62\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"39\";s:8:\"\u0000*\u0000epage\";s:2:\"46\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1368-5031\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"CAPO\";s:10:\"\u0000*\u0000aufirst\";s:4:\"J. P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:10:\"LARAMEE, C\";i:1;s:10:\"LUCENTE, V\";i:2;s:11:\"FAKHOURY, A\";i:3;s:23:\"FORERO-SCHWANHAEUSER, S\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:165:\"Solifenacin treatment for overactive bladder in Hispanic patients : patient-reported symptom bother and quality of life outcomes from the VESIcare\u00ae Open-Label Trial\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1742-1241.2007.01644.x\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1742-1241.2007.01644.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:165:\"Solifenacin treatment for overactive bladder in Hispanic patients : patient-reported symptom bother and quality of life outcomes from the VESIcare\u00ae Open-Label Trial\";s:9:\"\u0000*\u0000jtitle\";s:50:\"International journal of clinical practice (Esher)\";s:9:\"\u0000*\u0000stitle\";s:28:\"Int. j. clin. pract. (Esher)\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"62\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"39\";s:8:\"\u0000*\u0000epage\";s:2:\"46\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1368-5031\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"CAPO\";s:10:\"\u0000*\u0000aufirst\";s:4:\"J. P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:10:\"LARAMEE, C\";i:1;s:10:\"LUCENTE, V\";i:2;s:11:\"FAKHOURY, A\";i:3;s:23:\"FORERO-SCHWANHAEUSER, S\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:165:\"Solifenacin treatment for overactive bladder in Hispanic patients : patient-reported symptom bother and quality of life outcomes from the VESIcare\u00ae Open-Label Trial\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1742-1241.2007.01644.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:165:\"Solifenacin treatment for overactive bladder in Hispanic patients : patient-reported symptom bother and quality of life outcomes from the VESIcare\u00ae Open-Label Trial\";s:9:\"\u0000*\u0000jtitle\";s:50:\"International journal of clinical practice (Esher)\";s:9:\"\u0000*\u0000stitle\";s:28:\"Int. j. clin. pract. (Esher)\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"62\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"39\";s:8:\"\u0000*\u0000epage\";s:2:\"46\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1368-5031\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"CAPO\";s:10:\"\u0000*\u0000aufirst\";s:4:\"J. P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:10:\"LARAMEE, C\";i:1;s:10:\"LUCENTE, V\";i:2;s:11:\"FAKHOURY, A\";i:3;s:23:\"FORERO-SCHWANHAEUSER, S\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:165:\"Solifenacin treatment for overactive bladder in Hispanic patients : patient-reported symptom bother and quality of life outcomes from the VESIcare\u00ae Open-Label Trial\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1742-1241.2007.01644.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:165:\"Solifenacin treatment for overactive bladder in Hispanic patients : patient-reported symptom bother and quality of life outcomes from the VESIcare\u00ae Open-Label Trial\";s:9:\"\u0000*\u0000jtitle\";s:50:\"International journal of clinical practice (Esher)\";s:9:\"\u0000*\u0000stitle\";s:28:\"Int. j. clin. pract. (Esher)\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"62\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"39\";s:8:\"\u0000*\u0000epage\";s:2:\"46\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1368-5031\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"CAPO\";s:10:\"\u0000*\u0000aufirst\";s:4:\"J. P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:10:\"LARAMEE, C\";i:1;s:10:\"LUCENTE, V\";i:2;s:11:\"FAKHOURY, A\";i:3;s:23:\"FORERO-SCHWANHAEUSER, S\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:165:\"Solifenacin treatment for overactive bladder in Hispanic patients : patient-reported symptom bother and quality of life outcomes from the VESIcare\u00ae Open-Label Trial\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
